Why scientists focus on CBD research
Researchers are scientists who focus on CBD research at the molecular level. Over the past two decades, a large budget has been devoted to research. There are so many aspects that have been successfully researched and the results of this research have led to the CBD drug development process.
Scientists have reported that the hemp plant contains a large number of naturally occurring active cannabinoids such as cannabidiol (CBD) as well as the previously known tetrahydrocannabinol (THC). CBD does not contain any of the medicinal properties of the sister chemical THC and causes no chills or poisoning. Thus, it is the perfect foundation for a new age of medicines and treatments.
The potential antifungal, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-inflammatory and anti-cancer properties are researched and explored on a daily basis around the world, making it a perfect and organic active chemical for cosmetics and medicines.
Studies published by the Federation of American Societies for Experimental Studies have also shown that cannabinoids are responsible for the formation of lipids and therefore play an important role in the regulation and cure of skin diseases. In addition, these remedies are highly effective if implemented independently and locally.
CBD also serves to increase the rate of absorption of various skin chemicals to make CBD a healthy, safe and nourishing epidermis due to its properties in topical cosmetic software, and forms the perfect foundation for a new era of groundbreaking, compelling cosmetic means.
In addition, many review studies on the efficacy and safety of CBD have been reviewed in a variety of dosages, such as: As heavy and chronic doses, found in various treatments no significant side effects. The minimal effect of THC is based on the stimulation of CB1 receptors. CBD has a fairly low affinity for these receptors and when it binds, it produces little to no result. There is also increasing evidence that CBD behaves in additional brain signaling methods that may make a significant contribution to the therapeutic outcome.
Clinical trials are still needed to evaluate the clinical potential of CBD to get certain conditions. However, the preclinical study (such as both cell culture and animal models) has revealed that CBD has a range of consequences that could be therapeutically beneficial B. antimicrobial, antioxidant, neuroprotective, anti-inflammatory, analgesic and anti-inflammatory properties.
1. RW Steel, Miller JH, Sim DA, Tag DJ. Delta 9 tetrahydrocannabinol interferes with hippocampal neuroplasticity and neurogenesis in trained but untrained young Sprague-Dawley rats. Brain Res. 2014 Feb 22; 1548: 12-9.
2. Kalant, H. Effects of cannabis and cannabinoids in the human nervous system, effects of drugs in the human nervous system, BK Madras and MJ Kuhar eds, Elsevier 2014, ISBN: 978-0-12-418679-8.
3. Wittling PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J. Cannabinoide für medizinische Zwecke: Eine systematische Übersicht und Meta -Analyse. JAMA. 2015 Jun 23-30; 313 (24): 2456 & ndash; 73.
4. Lazary J., Juhasz G., Hunyady L., Bagdy G. Personalisierte Arzneimittel können den Weg für die sichere Anwendung von CB & sub1; -Rezeptorantagonisten ebnen. Trends Pharmacol Sci. 2011 Mai; 32 (5): 270 & ndash; 80.